Kezar Life Sciences’ Risk Disclosures Rely on Cross-References, Potentially Obscuring Full Risk Picture for InvestorsTip Ranks·May 12 at 06:01 AMKZR0.00%SBIO-2.42%
Aurinia Pharmaceuticals Completes Acquisition of Kezar Life SciencesTip Ranks·May 11 at 01:59 PMAUPH+1.12%KZR0.00%
Kevin Tang named CEO of Kezar Life Sciences as multiple directors and officers resignTradingView·May 11 at 01:33 PMKZR0.00%
Kezar Life Sciences Announced Transfer or Voluntary Withdrawal of ListingTradingView·May 11 at 01:33 PMKZR0.00%XBI-1.57%
Kezar Life Sciences, Inc. (NASDAQ:KZR) Given Consensus Recommendation of "Reduce" by AnalystsMarket Beat·May 5 at 08:12 AMKZR0.00%ARKG-1.15%
16:13 ETAre KZR, EQH, ULYX Obtaining Fair Deals for their Shareholders?prnewswire·Apr 14 at 08:14 PMULY0.00%EQH+0.10%
13:34 ETAre APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders?prnewswire·Apr 10 at 05:35 PMFBT-0.08%IHE-0.48%
14:15 ETSHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--KZR, CNTA, AFBI, and APLSprnewswire·Apr 8 at 06:17 PMIBB-0.89%ARKG-1.15%
Are KZR, TALK, WBD Obtaining Fair Deals for their Shareholders? | KZR Stock NewsStockTitan·Apr 7 at 10:47 AMWBD-0.75%UHS+2.26%
Kezar Life Sciences Announces Major Executive Leadership ChangesTip Ranks·Apr 3 at 09:27 PMLABU-4.79%ARKG-1.15%
Aurinia Pharmaceuticals to Acquire Kezar, Expanding Autoimmune PipelineTip Ranks·Apr 3 at 09:22 PMXBI-1.57%KZR0.00%
